🔎 Trials Near Me

Hjem › Ikke-småcellet lungekreft › Minnesota › Bloomington

Kliniske studier for Ikke-småcellet lungekreft i Bloomington, MN

10 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Bloomington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RekruttererFase 3
  • Fairview Southdale Hospital, Edina · 4 mi unna
  • Minnesota Oncology - Edina, Edina · 4 mi unna
  • Minnesota Oncology - Burnsville, Burnsville · 5 mi unna
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RekruttererFase 3
  • Fairview Southdale Hospital, Edina · 4 mi unna
  • Minnesota Oncology - Edina, Edina · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

RekruttererFase 3
  • Minnesota Oncology Hematology, P.A., Edina · 4 mi unna
  • Minnesota Oncology Hematology, PA, Burnsville · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • Minnesota Oncology Hematology, P.A., Edina · 4 mi unna
  • Minnesota Oncology Hematology, P.A., Burnsville · 5 mi unna
  • Minnesota Oncology Hematology, P.A., Chaska · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

RekruttererFase 3
  • M Health Fairview Cancer Clinic-Edina, Edina · 4 mi unna
  • Minnesota Oncology Hematology PA, Edina · 4 mi unna
  • Minnesota Oncology Hematology, PA, Burnsville · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

RekruttererFase 2
  • Fairview Southdale Hospital, Edina · 4 mi unna
  • Minnesota Oncology - Edina, Edina · 4 mi unna
  • Minnesota Oncology - Burnsville, Burnsville · 5 mi unna
  • og 2 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT03191149

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

RekruttererFase 2/3
  • Local Institution - 007-589A, Edina · 4 mi unna
  • USOR - Minnesota Oncology - Burnsville, Burnsville · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT04613596

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

RekruttererFase 2
  • Fairview Southdale Hospital, Edina · 4 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05642572

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RekruttererObservasjonsstudie
  • Fairview Southdale Hospital, Edina · 4 mi unna
  • Minnesota Oncology - Burnsville, Burnsville · 5 mi unna
  • Saint Francis Regional Medical Center, Shakopee · 12 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06418204

Ikke-småcellet lungekreft-studier i andre byer

Andre studier i Bloomington

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.